MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
MBRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Moleculin Biotech (MBRX) Ownership - Who owns Moleculin Biotech?

Moleculin Biotech Inc is a late-stage pharmaceutical development company currently evaluating Annamycin, also known as L-Annamycin and by its generic name naxtarubicin... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Pharmaceuticals Major
Address
5300 Memorial Drive
Phone
+1 713 300-5160
Employees
17
Web
https://www.moleculin.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
16.57M
P/E Ratio
N/A
Total Cash
10.32M
Projected Growth
N/A
Total Debt
326K
Revenue
N/A
Risk (Beta)
2.21
Dividend Yield
N/A
Total Cash/Share
1.93
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
MBRX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for MBRX
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry Biotechnology

Profile
Details
Industry
Pharmaceuticals Major
Address
5300 Memorial Drive
Phone
+1 713 300-5160
Employees
17
Web
https://www.moleculin.com